{"id":"https://openalex.org/W1964845997","doi":"https://doi.org/10.1158/1535-7163.mct-13-0084","title":"Sunitinib and SU11652 Inhibit Acid Sphingomyelinase, Destabilize Lysosomes, and Inhibit Multidrug Resistance","display_name":"Sunitinib and SU11652 Inhibit Acid Sphingomyelinase, Destabilize Lysosomes, and Inhibit Multidrug Resistance","alternate_titles":[],"publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W1964845997","doi":"https://doi.org/10.1158/1535-7163.mct-13-0084","mag":"1964845997","pmid":"https://pubmed.ncbi.nlm.nih.gov/23920274"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-13-0084","doi":"https://doi.org/10.1158/1535-7163.mct-13-0084","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0084","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964845997"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091611181","display_name":"Anne\u2010Marie Ellegaard","orcid":"https://orcid.org/0000-0002-4389-3908","observed_orcids":["https://orcid.org/0000-0002-4389-3908"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210148920","display_name":"Danish Cancer Society","ror":"https://ror.org/03ytt7k16","country_code":"DK","type":"nonprofit","lineage":["https://openalex.org/I4210148920"]}],"countries":["DK","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne-Marie Ellegaard","raw_affiliation_strings":["Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210148920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059992598","display_name":"Line Groth\u2010Pedersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210148920","display_name":"Danish Cancer Society","ror":"https://ror.org/03ytt7k16","country_code":"DK","type":"nonprofit","lineage":["https://openalex.org/I4210148920"]}],"countries":["DK","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Line Groth-Pedersen","raw_affiliation_strings":["Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210148920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040599736","display_name":"Viola M. J. Oorschot","orcid":"https://orcid.org/0000-0002-8122-8271","observed_orcids":["https://orcid.org/0000-0002-8122-8271"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210148920","display_name":"Danish Cancer Society","ror":"https://ror.org/03ytt7k16","country_code":"DK","type":"nonprofit","lineage":["https://openalex.org/I4210148920"]}],"countries":["DK","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Viola Oorschot","raw_affiliation_strings":["Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210148920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042911773","display_name":"Judith Klumperman","orcid":"https://orcid.org/0000-0003-4835-6228","observed_orcids":["https://orcid.org/0000-0003-4835-6228"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210148920","display_name":"Danish Cancer Society","ror":"https://ror.org/03ytt7k16","country_code":"DK","type":"nonprofit","lineage":["https://openalex.org/I4210148920"]}],"countries":["DK","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith Klumperman","raw_affiliation_strings":["Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210148920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045765682","display_name":"Thomas Kirkegaard","orcid":"https://orcid.org/0000-0001-5931-263X","observed_orcids":["https://orcid.org/0000-0001-5931-263X"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210148920","display_name":"Danish Cancer Society","ror":"https://ror.org/03ytt7k16","country_code":"DK","type":"nonprofit","lineage":["https://openalex.org/I4210148920"]}],"countries":["DK","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Kirkegaard","raw_affiliation_strings":["Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210148920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080458261","display_name":"Jesper Nylandsted","orcid":"https://orcid.org/0000-0001-6474-5093","observed_orcids":["https://orcid.org/0000-0001-6474-5093"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210148920","display_name":"Danish Cancer Society","ror":"https://ror.org/03ytt7k16","country_code":"DK","type":"nonprofit","lineage":["https://openalex.org/I4210148920"]}],"countries":["DK","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jesper Nylandsted","raw_affiliation_strings":["Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210148920"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076112400","display_name":"Marja J\u00e4\u00e4ttel\u00e4","orcid":"https://orcid.org/0000-0001-5950-7111","observed_orcids":["https://orcid.org/0000-0001-5950-7111"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210148920","display_name":"Danish Cancer Society","ror":"https://ror.org/03ytt7k16","country_code":"DK","type":"nonprofit","lineage":["https://openalex.org/I4210148920"]}],"countries":["DK","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marja J\u00e4\u00e4ttel\u00e4","raw_affiliation_strings":["Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cell Death and Metabolism, Danish Cancer Society Research Center; 2Orphazyme ApS, Copenhagen, Denmark; and 3Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210148920"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2279,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.87276203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"12","issue":"10","first_page":"2018","last_page":"2030"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.2858999967575073,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.2858999967575073,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.28299999237060547,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.14839999377727509,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/acid-sphingomyelinase","display_name":"acid sphingomyelinase","score":0.9319999814033508},{"id":"https://openalex.org/keywords/lysosomal-destabilization","display_name":"lysosomal destabilization","score":0.9419999718666077},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9459999799728394},{"id":"https://openalex.org/keywords/hsp70","display_name":"HSP70","score":0.968999981880188},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/apoptosis-resistance","display_name":"apoptosis resistance","score":0.5370000004768372},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.5649999976158142},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6259999871253967},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.421999990940094}],"concepts":[{"id":"https://openalex.org/C2776438761","wikidata":"https://www.wikidata.org/wiki/Q5206280","display_name":"DU145","level":5,"score":0.8945720195770264},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6042212843894958},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.599449634552002},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5046793222427368},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4802680015563965},{"id":"https://openalex.org/C2777851122","wikidata":"https://www.wikidata.org/wiki/Q424213","display_name":"Ceramide","level":3,"score":0.4736802875995636},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.45748937129974365},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41170161962509155},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4109446406364441},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.26665258407592773},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.20016714930534363},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1911066174507141},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077210","descriptor_name":"Sunitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008247","descriptor_name":"Lysosomes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013108","descriptor_name":"Sphingomyelin Phosphodiesterase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D061986","descriptor_name":"MCF-7 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1158/1535-7163.mct-13-0084","doi":"https://doi.org/10.1158/1535-7163.mct-13-0084","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-13-0084","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:23920274","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23920274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.936.722","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.936.722","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/early/2013/08/06/1535-7163.MCT-13-0084.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.939.9244","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.939.9244","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/early/2013/09/25/1535-7163.MCT-13-0084.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.954.5056","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.954.5056","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/12/10/2018.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W162515504","https://openalex.org/W1545184254","https://openalex.org/W1965247392","https://openalex.org/W1978111569","https://openalex.org/W1980792888","https://openalex.org/W1984579655","https://openalex.org/W1997355056","https://openalex.org/W2000571452","https://openalex.org/W2000614562","https://openalex.org/W2001402350","https://openalex.org/W2005727437","https://openalex.org/W2006434892","https://openalex.org/W2010884061","https://openalex.org/W2019005050","https://openalex.org/W2019363409","https://openalex.org/W2022520367","https://openalex.org/W2023633771","https://openalex.org/W2030410023","https://openalex.org/W2041973584","https://openalex.org/W2044256586","https://openalex.org/W2054462619","https://openalex.org/W2056467918","https://openalex.org/W2058291863","https://openalex.org/W2059499441","https://openalex.org/W2061690334","https://openalex.org/W2063127464","https://openalex.org/W2068102372","https://openalex.org/W2073055302","https://openalex.org/W2073133786","https://openalex.org/W2075088486","https://openalex.org/W2078543981","https://openalex.org/W2090985686","https://openalex.org/W2092592677","https://openalex.org/W2095220436","https://openalex.org/W2107736526","https://openalex.org/W2108205327","https://openalex.org/W2117253810","https://openalex.org/W2117365333","https://openalex.org/W2117692326","https://openalex.org/W2121311115","https://openalex.org/W2126483755","https://openalex.org/W2130081712","https://openalex.org/W2135233980","https://openalex.org/W2139552156","https://openalex.org/W2142280970","https://openalex.org/W2157815025","https://openalex.org/W2158520870","https://openalex.org/W2159970259","https://openalex.org/W2165618957","https://openalex.org/W2400015408"],"related_works":["https://openalex.org/W2041973584","https://openalex.org/W2160095658","https://openalex.org/W1912428744","https://openalex.org/W2051088915","https://openalex.org/W4308506817","https://openalex.org/W2011254357","https://openalex.org/W2093314430","https://openalex.org/W7164617446"],"abstract_inverted_index":{"Defective":[0],"apoptosis":[1],"signaling":[2],"and":[3,73,86,91,157,177],"multidrug":[4],"resistance":[5],"are":[6],"major":[7],"barriers":[8],"for":[9,28,227],"successful":[10],"cancer":[11,20,39,127,148,169,181,208],"treatment.":[12],"To":[13],"identify":[14],"drugs":[15],"capable":[16],"of":[17,34,98,112,160,198,215],"targeting":[18],"treatment-resistant":[19],"cells,":[21,61,156],"we":[22],"screened":[23],"small-molecule":[24],"kinase":[25,46],"inhibitor":[26],"libraries":[27],"compounds":[29],"that":[30,118,201],"decrease":[31],"the":[32,50,55,96,102,153],"viability":[33],"apoptosis-resistant":[35],"human":[36],"MCF7-Bcl-2":[37,60],"breast":[38],"cells.":[40,170],"SU11652,":[41],"a":[42,115,173,225],"multitargeting":[43],"receptor":[44],"tyrosine":[45],"inhibitor,":[47],"emerged":[48],"as":[49,150,152],"most":[51],"potent":[52],"compound":[53],"in":[54,84,166,207,219],"screen.":[56],"In":[57],"addition":[58],"to":[59,95,230],"it":[62,202],"effectively":[63,151,162],"killed":[64,144],"HeLa":[65],"cervix":[66],"carcinoma,":[67,72],"U-2-OS":[68],"osteosarcoma,":[69],"Du145":[70,146,167],"prostate":[71,147,168],"WEHI-S":[74],"fibrosarcoma":[75],"cells":[76,149],"at":[77],"low":[78],"micromolar":[79],"concentration.":[80],"SU11652":[81,143,161,199],"accumulated":[82],"rapidly":[83],"lysosomes":[85],"disturbed":[87],"their":[88],"pH":[89],"regulation":[90],"ultrastructure,":[92],"eventually":[93],"leading":[94],"leakage":[97],"lysosomal":[99,116,120,132],"proteases":[100],"into":[101],"cytosol.":[103],"Lysosomal":[104],"destabilization":[105],"was":[106],"preceded":[107],"by":[108,130,234],"an":[109],"early":[110],"inhibition":[111],"acid":[113,133],"sphingomyelinase,":[114],"lipase":[117],"promotes":[119],"membrane":[121],"stability.":[122],"Accordingly,":[123],"Hsp70,":[124],"which":[125],"supports":[126],"cell":[128],"survival":[129],"increasing":[131],"sphingomyelinase":[134],"activity,":[135,187],"conferred":[136],"partial":[137],"protection":[138],"against":[139],"SU11652-induced":[140],"cytotoxicity.":[141],"Remarkably,":[142],"multidrug-resistant":[145,164],"drug-sensitive":[154],"parental":[155],"subtoxic":[158],"concentrations":[159],"inhibited":[163],"phenotype":[165],"Notably,":[171],"sunitinib,":[172,211],"structurally":[174],"almost":[175],"identical":[176],"widely":[178],"used":[179],"antiangiogenic":[180],"drug,":[182],"exhibited":[183],"similar":[184],"lysosome-dependent":[185],"cytotoxic":[186],"albeit":[188],"with":[189,238],"significantly":[190,194],"lower":[191],"efficacy.":[192],"The":[193],"stronger":[195],"lysosome-targeting":[196],"activity":[197,218],"suggests":[200],"may":[203],"display":[204],"better":[205],"efficacy":[206],"treatment":[209],"than":[210],"encouraging":[212],"further":[213],"evaluation":[214],"its":[216],"anticancer":[217],"vivo.":[220],"Furthermore,":[221],"our":[222],"data":[223],"provide":[224],"rationale":[226],"novel":[228],"approaches":[229],"target":[231],"drug-resistant":[232],"cancers":[233],"combining":[235],"classic":[236],"chemotherapy":[237],"sunitinib":[239],"or":[240],"SU11652.":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964845997","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
